The Fox Chase Chemical Diversity Center Announces that it Has Been Awarded a Phase II SBIR Grant, “Development of Small Antimicrobial Peptide Mimics,” Totaling $2,000,000.
Doylestown, PA. August 23, 2013- FCCDC is pleased to announce that is has been awarded a Phase II SBIR grant (7R44AI090762-04), “Development of Small Antimicrobial Peptide Mimics” ($2,000,000).